European Archives - Page 16 of 1392 - European Medical Journal

Large-Volume BPH May Benefit from Modified Water Vapour Treatment

Modified water vapour thermal therapy significantly improved symptoms, urinary flow, and quality of life in men with large-volume BPH, with low complication rates.

Twenty-Year Study Reveals Cognitive Training Reduces Dementia Risk

Long-term trial data suggest speed-based cognitive training with boosters may reduce the risk of dementia diagnosis years later.

Maternal Kidney Disease Linked to Higher Congenital Malformation Risk

A nationwide cohort study finds higher rates of congenital malformations in babies born to mothers with chronic and end-stage kidney disease.

High Sugar Drink Intake Linked to COPD Risk

A new study finds adults consuming more sugary drinks have higher odds of COPD, highlighting links between diet, lung health, and overall wellbeing.

AMH and AFC Do Not Predict Embryo Euploidy in IVF

AMH and AFC levels do not independently predict embryo euploidy in patients undergoing IVF, a 2026 cohort study has found.

Quantitative Coronary CT Plaque Measures Predict MACE Risk

Quantitative Coronary CT Plaque Measures Predict MACE Risk

Quantitative coronary CT plaque measures independently predicted major adverse cardiovascular events, improving risk stratification in patients.

Self-Management Intervention Targets Early Inflammatory Arthritis

Self-Management Intervention Targets Early Inflammatory Arthritis

A multicentre trial will assess whether a nurse led self management intervention improves skills and quality of life in adults with newly diagnosed inflammatory arthritis.

Stopping Washcloth Use May Reduce Pruritus, Study Suggests

Stopping Washcloth Use May Reduce Pruritus, Study Suggests

Stopping washcloth use during bathing may significantly reduce chronic itch, according to a new observational dermatology study exploring simple lifestyle changes.

AI Medical Assistants Fail due to User Misinterpretation

AI Medical Assistants Fail due to User Misinterpretation

A UK study shows AI medical assistants perform well alone but fail to improve public health decisions in practice.

High Complete Response Rate with Neoadjuvant Pembrolizumab

High Complete Response Rate with Neoadjuvant Pembrolizumab

Phase 2 findings show neoadjuvant pembrolizumab produced a 71% pathological complete response rate in resectable desmoplastic melanoma, with favourable safety and three year follow up outcomes.